시장보고서
상품코드
1812421

흉막 생검 시장 : 제품 유형별, 절차별, 진단 용도별, 가이드 방법별, 최종 사용자별, 지역별

Pleural Biopsy Market, By Product Type, By Technique, By Diagnostic Application, By Guidance Method, By End User, By Geography

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

흉막 생검 시장은 2025년에는 3억 3,040만 달러로 추정되고, 2032년까지 5억 340만 달러에 이를 것으로 예측되며, 2025-2032년에 걸쳐 CAGR 6.2%로 성장할 전망입니다.

보고 범위 보고서 세부정보
기준 연도 2024년 시장 매출(2025년) 3억 3,040만 달러
실적 데이터 2020-2024년 예측 기간 2020-2024년
예측 기간(2025-2032년)의 CAGR : 6.20% 금액 예측(2032년) 5억 340만 달러

세계의 흉막 생검 시장은 진단 의료 미래 내 핵심 부문으로, 병리학적 검사를 위해 흉막에서 조직 샘플을 채취하는 절차 및 기술이 포함됩니다. 흉막 생검 절차는 악성 흉막 중피종, 폐암 전이, 결핵 및 기타 염증성 또는 감염성 흉막 질환을 포함한 다양한 흉막 질환을 식별하는 필수 진단 도구 역할을 합니다. 이 시장은 에이브럼스(Abrams) 또는 코프(Cope) 바늘을 이용한 폐쇄성 흉막 생검, 흉강경 시술, CT 유도 경피적 생검 등 다양한 시술 방식을 포함하며, 각각 진단 정확도와 환자 안전 측면에서 고유한 장점을 제공합니다.

호흡기 질환의 증가하는 유병률, 발암 물질에 대한 환경적 노출 증가, 조기 질환 발견에 대한 인식 제고가 시장 성장을 상당하게 촉진했습니다. 전 세계 의료 시스템은 영상 유도 시스템과 최소 침습 기법의 통합을 통해 흉막 생검 절차가 점점 정교해지면서 첨단 진단 기술에 대한 상당한 투자를 있습니다. 생검 장치의 기술적 발전, 개선된 절차 안전 프로토콜, 향상된 진단 정확도는 시장의 진화를 더욱 촉진하여 흉막 생검을 전 세계 최근 폐 및 흉부 의학 진료의 필수 컴포넌트로 만들고 있습니다.

시장 역학

세계의 흉막 생검 시장은 여러 상호 연결된 요인에 의해 견고한 성장을 경험하고 있습니다. 폐암 및 중피종 발생률 증가는 주요 성장 촉매제로 작용하며, 특히 전 세계 고령 인구에서 석면 및 기타 발암 물질에 대한 환경적 및 직업적 노출이 지속적으로 나타나고 있습니다. 고급 영상 유도 생검 시스템 개발, 최소 침습 흉강경 기술, 정밀도와 안전성이 향상된 바늘 생검 장비 등 첨단 기술 혁신은 시술 합병증을 감축하면서 더 정확한 진단을 가능하게 함으로써 시장을 상당한 폭으로 촉진하고 있습니다.

조기 질병 발견과 맞춤형 의약품 접근법에 대한 강조가 증가함에 따라 시장 성장은 더욱 가속화되고 있습니다. 의료 제공자들은 분자 진단 및 표적 치료 선택을 위해 고품질 조직 샘플 확보의 중요성을 점점 더 인식하고 있기 때문입니다. 전 세계 흉막 생검 시장은 여러 상호 연관된 요인에 의해 견고한 성장을 경험하고 있습니다. 주요 성장 촉진제는 폐암 및 중피종 발생률 증가이며, 특히 석면 및 기타 발암 물질에 대한 환경적 및 직업적 노출이 전 세계적으로 고령 인구에 계속 영향을 미치고 있기 때문입니다.

새로운 생검 기기에 대한 규제적 과제와 긴 승인 절차 역시 시장 성장을 저해합니다. 그럼에도 불구하고 신흥 경제국의 의료 인프라 확대, 의료비 지출 증가, 의료 관광 확대, 그리고 인공 지능 및 로봇 지원을 접목한 향후 생검 기술 개발을 통해 상당한 기회가 도래하고 있습니다. 이러한 기술들은 시술 정확도를 향상시키고, 합병증을 감소시키며, 전 세계 더 광범위한 환자 집단에 흉막 생검 시술의 접근성을 확대할 것으로 기대됩니다.

본 조사의 주요 특징

  • 본 보고서는 세계의 흉막 생검 시장을 상세하게 분석하여 2024년을 기준 연도로 한 예측기간(2025-2032년) 시장 규모 및 연평균 성장률(CAGR%)을 제공합니다.
  • 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
  • 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
  • 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 업적, 전략 등의 매개변수를 바탕으로 세계의 흉막 생검 시장에서 주요 기업을 프로파일링합니다.
  • 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진이 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
  • 세계의 흉막 생검 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자는 세계의 흉막 생검 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정을 용이하게 할 수 있습니다.

목차

제1장 조사의 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 전망

  • 보고서 설명
    • 시장 정의와 범위
  • 주요 요약

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
  • 성장 촉진요인
  • 억제요인
  • 기회
  • 영향 분석
  • 주요 발전
  • 규제 시나리오
  • 제품 출시 및 승인
  • PEST 분석
  • PORTER 분석
  • 합병과 인수 시나리오
  • 업계 동향

제4장 세계의 흉막 생검 시장, 제품 유형별(2020-2032년)

  • 생검침 및 기구
  • 흉강경 및 부속품
  • 이미징 및 유도 시스템
  • 보조기구(흡인기, 집게, 키트 등)

제5장 세계의 흉막 생검 시장, 기술별(2020-2032년)

  • 바늘 생검(폐쇄 바늘, 에이브람스 바늘)
  • 흉강경 흉막 생검(의료용 흉강경 검사/VATS)
  • 개흉 흉막 생검

제6장 세계의 흉막 생검 시장, 진단 용도별(2020-2032년)

  • 악성 흉수 및 흉막 악성 종양(예 : 중피종, 전이성 암)
  • 감염성 흉막 질환(예 : 결핵, 세균성/진균성 흉막염)
  • 염증성 및 자가면역성 질환(예 : 류마티스성 흉막염, 루푸스)
  • 기타 특발성 또는 원인 불명의 흉수

제7장 세계의 흉막 생검 시장, 가이드 방법별(2020-2032년)

  • 영상 유도(CT 유도, 초음파 유도)
  • 비유도

제8장 세계의 흉막 생검 시장, 최종 사용자별(2020-2032년)

  • 병원
  • 전문 클리닉
  • 진단센터
  • 외래수술센터(ASC)
  • 학술기관 및 연구기관

제9장 세계의 흉막 생검 시장, 지역별(2020-2032년)

  • 북미
      • 미국
      • 캐나다
  • 라틴아메리카
      • 브라질
      • 아르헨티나
      • 멕시코
      • 기타 라틴아메리카
  • 유럽
      • 독일
      • 영국
      • 스페인
      • 프랑스
      • 이탈리아
      • 러시아
      • 기타 유럽
  • 아시아태평양
      • 중국
      • 인도
      • 일본
      • 호주
      • 한국
      • ASEAN
      • 기타 아시아태평양
  • 중동
      • GCC 국가
      • 이스라엘
      • 기타 중동
  • 아프리카
      • 남아프리카
      • 북아프리카
      • 중앙 아프리카

제10장 경쟁 구도

  • Olympus Corporation
  • Boston Scientific Corporation
  • Cook Medical
  • CONMED Corporation
  • Medtronic plc
  • Braun Melsungen AG
  • Hologic Inc.
  • BD(Becton, Dickinson and Company)
  • FUJIFILM Holdings Corporation
  • KARL STORZ SE & Co. KG
  • Ethicon(Johnson & Johnson)
  • Argon Medical Devices
  • Richard Wolf GmbH
  • Smiths Medical

제11장 애널리스트의 제안

  • 기회
  • 애널리스트의 견해
  • 일관된 기회 지도

제12장 참고문헌과 조사방법

  • 참고문헌
  • 조사 방법
  • 출판사에 대해
HBR 25.09.29

Pleural Biopsy Market is estimated to be valued at USD 330.4 Mn in 2025 and is expected to reach USD 503.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 330.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.20% 2032 Value Projection: USD 503.4 Mn

The global pleural biopsy market represents a critical segment within the diagnostic healthcare landscape, encompassing procedures and technologies designed to extract tissue samples from the pleura for pathological examination. Pleural biopsy procedures serve as essential diagnostic tools for identifying various pleural conditions, including malignant pleural mesothelioma, lung cancer metastases, tuberculosis, and other inflammatory or infectious pleural diseases. The market encompasses multiple procedural approaches, including closed pleural biopsy using Abrams or Cope needles, thoracoscopic procedures, and CT-guided percutaneous biopsies, each offering distinct advantages in terms of diagnostic accuracy and patient safety.

The increasing prevalence of respiratory diseases, coupled with rising environmental exposure to carcinogenic substances and growing awareness of early disease detection, has significantly propelled market growth. Healthcare systems worldwide are witnessing substantial investments in advanced diagnostic technologies, with pleural biopsy procedures becoming increasingly sophisticated through integration of imaging guidance systems and minimally invasive techniques. The market's evolution is further driven by technological advancements in biopsy instruments, improved procedural safety protocols, and enhanced diagnostic accuracy, making pleural biopsy an indispensable component of modern pulmonary and thoracic medicine practices globally.

Market Dynamics

The global pleural biopsy market is experiencing robust growth, driven by multiple interconnected factors. The increasing incidence of lung cancer and mesothelioma serves as a primary growth catalyst, particularly as environmental and occupational exposures to asbestos and other carcinogenic substances continue to manifest in aging populations worldwide. Advanced technological innovations, including the development of sophisticated imaging-guided biopsy systems, minimally invasive thoracoscopic techniques, and enhanced needle biopsy instruments with improved precision and safety profiles, significantly drive market expansion by enabling more accurate diagnoses with reduced procedural complications.

The growing emphasis on early disease detection and personalized medicine approaches further accelerates market growth, as healthcare providers increasingly recognize the critical importance of obtaining high-quality tissue samples for molecular diagnostics and targeted therapy selection. The global pleural biopsy market is experiencing robust growth, driven by multiple interconnected factors. A key growth catalyst is the rising incidence of lung cancer and mesothelioma, especially as environmental and occupational exposures to asbestos and other carcinogenic substances continue to affect aging populations worldwide.

Regulatory challenges and lengthy approval processes for new biopsy devices also impede market growth. Nevertheless, significant opportunities emerge through expanding healthcare infrastructure in emerging economies, increasing healthcare expenditure, growing medical tourism, and the development of next-generation biopsy technologies incorporating artificial intelligence and robotic assistance, which promise to enhance procedural accuracy, reduce complications, and expand the accessibility of pleural biopsy procedures to broader patient populations globally.

Key Features of the Study

  • This report provides in-depth analysis of the global pleural biopsy market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pleural biopsy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Olympus Corporation, Boston Scientific Corporation, Cook Medical, CONMED Corporation, Medtronic plc, B. Braun Melsungen AG, Hologic Inc., BD (Becton, Dickinson and Company), FUJIFILM Holdings Corporation, KARL STORZ SE & Co. KG, Ethicon (Johnson & Johnson), Argon Medical Devices, Richard Wolf GmbH, and Smiths Medical
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pleural biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pleural biopsy market

Market Segmentation

  • Product Type Insights (Revenue, USD Mn, 2020 - 2032)
    • Biopsy Needles and Instruments
    • Thoracoscopes and Accessories
    • Imaging and Guidance Systems
    • Ancillary Equipment (suction devices, forceps, kits, etc.)
  • Technique Insights (Revenue, USD Mn, 2020 - 2032)
    • Needle Biopsy (Closed Needle/Abrams Needle)
    • Thoracoscopic Pleural Biopsy (Medical Thoracoscopy/VATS)
    • Open Surgical Pleural Biopsy
  • Diagnostic Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Malignant Pleural Effusion and Pleural Malignancies (e.g., mesothelioma, metastatic cancers)
    • Infectious Pleural Diseases (e.g., tuberculosis, bacterial/fungal pleuritis)
    • Inflammatory and Autoimmune Conditions (e.g., rheumatoid pleuritis, lupus)
    • Other Idiopathic or Unexplained Pleural Effusions
  • Guidance Method Insights (Revenue, USD Mn, 2020 - 2032)
    • Image-Guided (CT-guided, Ultrasound-guided)
    • Non-Guided
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
    • Ambulatory Surgical Centers
    • Academic and Research Institutes
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Olympus Corporation
    • Boston Scientific Corporation
    • Cook Medical
    • CONMED Corporation
    • Medtronic plc
    • Braun Melsungen AG
    • Hologic Inc.
    • BD (Becton, Dickinson and Company)
    • FUJIFILM Holdings Corporation
    • KARL STORZ SE & Co. KG
    • Ethicon (Johnson & Johnson)
    • Argon Medical Devices
    • Richard Wolf GmbH
    • Smiths Medical

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Pleural Biopsy Market, By Product Type
    • Global Pleural Biopsy Market, By Technique
    • Global Pleural Biopsy Market, By Diagnostic Application
    • Global Pleural Biopsy Market, By Guidance Method
    • Global Pleural Biopsy Market, By End User
    • Global Pleural Biopsy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Pleural Biopsy Market, By Product Type, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Biopsy Needles and Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Thoracoscopes and Accessories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Imaging and Guidance Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Ancillary Equipment (suction devices, forceps, kits, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Pleural Biopsy Market, By Technique, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Needle Biopsy (Closed Needle/Abrams Needle)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Thoracoscopic Pleural Biopsy (Medical Thoracoscopy/VATS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Open Surgical Pleural Biopsy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Pleural Biopsy Market, By Diagnostic Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Malignant Pleural Effusion and Pleural Malignancies (e.g., mesothelioma, metastatic cancers)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Infectious Pleural Diseases (e.g., tuberculosis, bacterial/fungal pleuritis)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Inflammatory and Autoimmune Conditions (e.g., rheumatoid pleuritis, lupus)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Other Idiopathic or Unexplained Pleural Effusions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Pleural Biopsy Market, By Guidance Method, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Image-Guided (CT-guided, Ultrasound-guided)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Non-Guided
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Pleural Biopsy Market, By End User, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Pleural Biopsy Market, By Region, 2020 - 2032, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Technique, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Diagnostic Application, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Guidance Method, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive landscape

  • Olympus Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cook Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CONMED Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Braun Melsungen AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hologic Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BD (Becton, Dickinson and Company)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • FUJIFILM Holdings Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • KARL STORZ SE & Co. KG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ethicon (Johnson & Johnson)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Argon Medical Devices
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Richard Wolf GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Smiths Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제